Logo image of INV

INNVENTURE INC (INV) Stock Fundamental Analysis

USA - NASDAQ:INV - US45784M1080 - Common Stock

5.8 USD
-0.42 (-6.75%)
Last: 10/2/2025, 10:14:22 AM
Fundamental Rating

2

Overall INV gets a fundamental rating of 2 out of 10. We evaluated INV against 237 industry peers in the Capital Markets industry. INV may be in some trouble as it scores bad on both profitability and health. INV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

INV had negative earnings in the past year.
In the past year INV has reported a negative cash flow from operations.
In multiple years INV reported negative net income over the last 5 years.
INV had a negative operating cash flow in each of the past 5 years.
INV Yearly Net Income VS EBIT VS OCF VS FCFINV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

INV has a worse Return On Assets (-52.56%) than 94.94% of its industry peers.
The Return On Equity of INV (-133.43%) is worse than 88.61% of its industry peers.
Industry RankSector Rank
ROA -52.56%
ROE -133.43%
ROIC N/A
ROA(3y)-48.45%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
INV Yearly ROA, ROE, ROICINV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for INV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
INV Yearly Profit, Operating, Gross MarginsINV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -2K -4K -6K

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, INV has about the same amount of shares outstanding.
INV has a better debt/assets ratio than last year.
INV Yearly Shares OutstandingINV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M
INV Yearly Total Debt VS Total AssetsINV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

INV has an Altman-Z score of -0.93. This is a bad value and indicates that INV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.93, INV is doing worse than 83.12% of the companies in the same industry.
INV has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
INV has a better Debt to Equity ratio (0.08) than 81.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z -0.93
ROIC/WACCN/A
WACCN/A
INV Yearly LT Debt VS Equity VS FCFINV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 0.29 indicates that INV may have some problems paying its short term obligations.
The Current ratio of INV (0.29) is worse than 81.01% of its industry peers.
A Quick Ratio of 0.20 indicates that INV may have some problems paying its short term obligations.
The Quick ratio of INV (0.20) is worse than 86.92% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.2
INV Yearly Current Assets VS Current LiabilitesINV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for INV have decreased strongly by -1737.15% in the last year.
INV shows a strong growth in Revenue. In the last year, the Revenue has grown by 562.33%.
EPS 1Y (TTM)-1737.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-900%
Revenue 1Y (TTM)562.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%113.45%

3.2 Future

INV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.74% yearly.
The Revenue is expected to grow by 469.11% on average over the next years. This is a very strong growth
EPS Next Y-286.67%
EPS Next 2Y29.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year461.11%
Revenue Next 2Y469.11%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

INV Yearly Revenue VS EstimatesINV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 10M 20M 30M 40M
INV Yearly EPS VS EstimatesINV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -1 -2 -3 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INV. In the last year negative earnings were reported.
Also next year INV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INV Price Earnings VS Forward Price EarningsINV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INV Per share dataINV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6

4.3 Compensation for Growth

A more expensive valuation may be justified as INV's earnings are expected to grow with 29.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.74%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

INV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNVENTURE INC

NASDAQ:INV (10/2/2025, 10:14:22 AM)

5.8

-0.42 (-6.75%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)N/A N/A
Inst Owners12.05%
Inst Owner Change240.81%
Ins Owners22.81%
Ins Owner Change4.37%
Market Cap324.97M
Analysts80
Price Target14.79 (155%)
Short Float %2.8%
Short Ratio2.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)576.9%
Min EPS beat(2)-916.5%
Max EPS beat(2)2070.3%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-47.2%
Min Revenue beat(2)-63.04%
Max Revenue beat(2)-31.37%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)18.18%
EPS NQ rev (3m)5.26%
EPS NY rev (1m)-37.69%
EPS NY rev (3m)-37.69%
Revenue NQ rev (1m)-48.71%
Revenue NQ rev (3m)-51.35%
Revenue NY rev (1m)-49.94%
Revenue NY rev (3m)-49.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 220.02
P/FCF N/A
P/OCF N/A
P/B 1.48
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.25
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-1.25
FCFYN/A
OCF(TTM)-1.23
OCFYN/A
SpS0.03
BVpS3.91
TBVpS-4.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -52.56%
ROE -133.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-48.45%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.56%
Cap/Sales 84.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.2
Altman-Z -0.93
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1737.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-900%
EPS Next Y-286.67%
EPS Next 2Y29.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)562.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%113.45%
Revenue Next Year461.11%
Revenue Next 2Y469.11%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-527.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17462.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17150%
OCF growth 3YN/A
OCF growth 5YN/A